International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies

Dominick Angiolillo , Fabiana Rollini , Robert Storey , Deepak Bhatt (1) , Stefan James (2) , David Schneider (3) , Dirk Sibbing , Derek Y.F. So , Dietmar Trenk , Dimitrios Alexopoulos , Paul Gurbel , Willibald Hochholzer , Leonardo de Luca , Laurent Bonello (4) , Daniel Aradi , Thomas Cuisset (5) , Udaya Tantry , Tracy Wang , Marco Valgimigli , Ron Waksman , Roxana Mehran (6) , Gilles Montalescot (7) , Francesco Franchi , Matthew Price

1 VA Boston Healthcare System
2 Uppsala Clinical Research Centre
3 Fraunhofer HHI - Fraunhofer Institute for Telecommunications - Heinrich Hertz Institute
4 Physiopathologie de l'Endothelium
5 NORT - Nutrition, obésité et risque thrombotique
6 Cardiovascular Research Foundation
7 CHU Pitié-Salpêtrière [AP-HP]

Domaines: Sciences du Vivant [q-bio]; Médecine humaine et pathologie

Dominick Angiolillo, Fabiana Rollini, Robert Storey, Deepak Bhatt, Stefan James, et al.. International Expert Consensus on Switching Platelet P2Y 12 Receptor–Inhibiting Therapies. Circulation, 2017, 136 (20), pp.1955 - 1975. ⟨10.1161/CIRCULATIONAHA.117.031164⟩. ⟨hal-01744657⟩